Concourse Financial Group Securities’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 637 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2721 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2715 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2759 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 2774 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2732 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2748 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2756 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2757 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2700 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2476 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2572 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2533 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2713 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2730 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2675 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 2631 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2577 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2440 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2350 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2425 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2348 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2047 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2470 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2483 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2352 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1886 |
|